Martin Demarchi

Icans
Strasbourg, FR 
Icans
Strasbourg, FR 

Overview

Martin Demarchi practices practicing medicine in Strasbourg, France.

His clinical expertise encompasses Agranulocytosis, Ovarian Cancer, Febrile Neutropenia, and Lymphadenectomy.

He is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

ICANS
Strasbourg, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Diagnostic test, Other
Study Phase: Not Applicable
A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma
A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma
Enrollment Status: Unknown
Publish Date: February 13, 2024
Intervention Type: Drug
Study Drugs: AZD2014, Anastrozole
Study Phase: Phase 1/Phase 2
Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI.
Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI.
Enrollment Status: Completed
Publish Date: April 07, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 2 Less Clinical Trials

21 Total Publications

Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review.
Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review.
Journal: Cancers
Published: September 25, 2023

Frequently Asked Questions about Martin Demarchi

Is Martin Demarchi a top-rated expert for Agranulocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Martin Demarchi is classified as an Experienced expert for Agranulocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin Demarchi participate in research or clinical trials?

Yes. Martin Demarchi has published 21 articles and abstracts on conditions like Agranulocytosis. You can view a list of Martin Demarchi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Demarchi's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile